Personalized Medicine-EMEA Market Status and Trend Report 2013-2023
Report Summary
Personalized Medicine-EMEA Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Personalized Medicine industry, standing on the readers’ perspective, delivering detailed market data and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Whole EMEA and Regional Market Size of Personalized Medicine 2013-2017, and development forecast 2018-2023
Main market players of Personalized Medicine in EMEA, with company and product introduction, position in the Personalized Medicine market
Market status and development trend of Personalized Medicine by types and applications
Cost and profit status of Personalized Medicine, and marketing status
Market growth drivers and challenges
The report segments the EMEA Personalized Medicine market as:
EMEA Personalized Medicine Market: Regional Segment Analysis (Regional Consumption Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):
Europe
Middle East
Africa
EMEA Personalized Medicine Market: Product Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
Diagnostic
Therapeutics
Medical Care
Nutrition
Wellness
EMEA Personalized Medicine Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
Hospitals
Molecular Diagnostic Laboratories and Testing Centers
Academic Institutes
Bio and Health Informatics Companies
Others
EMEA Personalized Medicine Market: Players Segment Analysis (Company and Product introduction, Personalized Medicine Sales Volume, Revenue, Price and Gross Margin):
Laboratory Corporation of America
Quest Diagnostics
Abbott, Becton Dickinson & Co
Siemens Healthcare Diagnostics Inc
GE Healthcare
Pfizer Inc
Sanofi
CardioDx
Asuragen Inc
Bristol-Myers Squibb
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
Personalized Medicine-EMEA Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Personalized Medicine industry, standing on the readers’ perspective, delivering detailed market data and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Whole EMEA and Regional Market Size of Personalized Medicine 2013-2017, and development forecast 2018-2023
Main market players of Personalized Medicine in EMEA, with company and product introduction, position in the Personalized Medicine market
Market status and development trend of Personalized Medicine by types and applications
Cost and profit status of Personalized Medicine, and marketing status
Market growth drivers and challenges
The report segments the EMEA Personalized Medicine market as:
EMEA Personalized Medicine Market: Regional Segment Analysis (Regional Consumption Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):
Europe
Middle East
Africa
EMEA Personalized Medicine Market: Product Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
Diagnostic
Therapeutics
Medical Care
Nutrition
Wellness
EMEA Personalized Medicine Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
Hospitals
Molecular Diagnostic Laboratories and Testing Centers
Academic Institutes
Bio and Health Informatics Companies
Others
EMEA Personalized Medicine Market: Players Segment Analysis (Company and Product introduction, Personalized Medicine Sales Volume, Revenue, Price and Gross Margin):
Laboratory Corporation of America
Quest Diagnostics
Abbott, Becton Dickinson & Co
Siemens Healthcare Diagnostics Inc
GE Healthcare
Pfizer Inc
Sanofi
CardioDx
Asuragen Inc
Bristol-Myers Squibb
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
CHAPTER 1 OVERVIEW OF PERSONALIZED MEDICINE
1.1 Definition of Personalized Medicine in This Report
1.2 Commercial Types of Personalized Medicine
1.2.1 Diagnostic
1.2.2 Therapeutics
1.2.3 Medical Care
1.2.4 Nutrition
1.2.5 Wellness
1.3 Downstream Application of Personalized Medicine
1.3.1 Hospitals
1.3.2 Molecular Diagnostic Laboratories and Testing Centers
1.3.3 Academic Institutes
1.3.4 Bio and Health Informatics Companies
1.3.5 Others
1.4 Development History of Personalized Medicine
1.5 Market Status and Trend of Personalized Medicine 2013-2023
1.5.1 EMEA Personalized Medicine Market Status and Trend 2013-2023
1.5.2 Regional Personalized Medicine Market Status and Trend 2013-2023
CHAPTER 2 EMEA MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Status of Personalized Medicine in EMEA 2013-2017
2.2 Consumption Market of Personalized Medicine in EMEA by Regions
2.2.1 Consumption Volume of Personalized Medicine in EMEA by Regions
2.2.2 Revenue of Personalized Medicine in EMEA by Regions
2.3 Market Analysis of Personalized Medicine in EMEA by Regions
2.3.1 Market Analysis of Personalized Medicine in Europe 2013-2017
2.3.2 Market Analysis of Personalized Medicine in Middle East 2013-2017
2.3.3 Market Analysis of Personalized Medicine in Africa 2013-2017
2.4 Market Development Forecast of Personalized Medicine in EMEA 2018-2023
2.4.1 Market Development Forecast of Personalized Medicine in EMEA 2018-2023
2.4.2 Market Development Forecast of Personalized Medicine by Regions 2018-2023
CHAPTER 3 EMEA MARKET STATUS AND FORECAST BY TYPES
3.1 Whole EMEA Market Status by Types
3.1.1 Consumption Volume of Personalized Medicine in EMEA by Types
3.1.2 Revenue of Personalized Medicine in EMEA by Types
3.2 EMEA Market Status by Types in Major Countries
3.2.1 Market Status by Types in Europe
3.2.2 Market Status by Types in Middle East
3.2.3 Market Status by Types in Africa
3.3 Market Forecast of Personalized Medicine in EMEA by Types
CHAPTER 4 EMEA MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Demand Volume of Personalized Medicine in EMEA by Downstream Industry
4.2 Demand Volume of Personalized Medicine by Downstream Industry in Major Countries
4.2.1 Demand Volume of Personalized Medicine by Downstream Industry in Europe
4.2.2 Demand Volume of Personalized Medicine by Downstream Industry in Middle East
4.2.3 Demand Volume of Personalized Medicine by Downstream Industry in Africa
4.3 Market Forecast of Personalized Medicine in EMEA by Downstream Industry
CHAPTER 5 MARKET DRIVING FACTOR ANALYSIS OF PERSONALIZED MEDICINE
5.1 EMEA Economy Situation and Trend Overview
5.2 Personalized Medicine Downstream Industry Situation and Trend Overview
CHAPTER 6 PERSONALIZED MEDICINE MARKET COMPETITION STATUS BY MAJOR PLAYERS IN EMEA
6.1 Sales Volume of Personalized Medicine in EMEA by Major Players
6.2 Revenue of Personalized Medicine in EMEA by Major Players
6.3 Basic Information of Personalized Medicine by Major Players
6.3.1 Headquarters Location and Established Time of Personalized Medicine Major Players
6.3.2 Employees and Revenue Level of Personalized Medicine Major Players
6.4 Market Competition News and Trend
6.4.1 Merger, Consolidation or Acquisition News
6.4.2 Investment or Disinvestment News
6.4.3 New Product Development and Launch
CHAPTER 7 PERSONALIZED MEDICINE MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
7.1 Laboratory Corporation of America
7.1.1 Company profile
7.1.2 Representative Personalized Medicine Product
7.1.3 Personalized Medicine Sales, Revenue, Price and Gross Margin of Laboratory Corporation of America
7.2 Quest Diagnostics
7.2.1 Company profile
7.2.2 Representative Personalized Medicine Product
7.2.3 Personalized Medicine Sales, Revenue, Price and Gross Margin of Quest Diagnostics
7.3 Abbott, Becton Dickinson & Co
7.3.1 Company profile
7.3.2 Representative Personalized Medicine Product
7.3.3 Personalized Medicine Sales, Revenue, Price and Gross Margin of Abbott, Becton Dickinson & Co
7.4 Siemens Healthcare Diagnostics Inc
7.4.1 Company profile
7.4.2 Representative Personalized Medicine Product
7.4.3 Personalized Medicine Sales, Revenue, Price and Gross Margin of Siemens Healthcare Diagnostics Inc
7.5 GE Healthcare
7.5.1 Company profile
7.5.2 Representative Personalized Medicine Product
7.5.3 Personalized Medicine Sales, Revenue, Price and Gross Margin of GE Healthcare
7.6 Pfizer Inc
7.6.1 Company profile
7.6.2 Representative Personalized Medicine Product
7.6.3 Personalized Medicine Sales, Revenue, Price and Gross Margin of Pfizer Inc
7.7 Sanofi
7.7.1 Company profile
7.7.2 Representative Personalized Medicine Product
7.7.3 Personalized Medicine Sales, Revenue, Price and Gross Margin of Sanofi
7.8 CardioDx
7.8.1 Company profile
7.8.2 Representative Personalized Medicine Product
7.8.3 Personalized Medicine Sales, Revenue, Price and Gross Margin of CardioDx
7.9 Asuragen Inc
7.9.1 Company profile
7.9.2 Representative Personalized Medicine Product
7.9.3 Personalized Medicine Sales, Revenue, Price and Gross Margin of Asuragen Inc
7.10 Bristol-Myers Squibb
7.10.1 Company profile
7.10.2 Representative Personalized Medicine Product
7.10.3 Personalized Medicine Sales, Revenue, Price and Gross Margin of Bristol-Myers Squibb
CHAPTER 8 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF PERSONALIZED MEDICINE
8.1 Industry Chain of Personalized Medicine
8.2 Upstream Market and Representative Companies Analysis
8.3 Downstream Market and Representative Companies Analysis
CHAPTER 9 COST AND GROSS MARGIN ANALYSIS OF PERSONALIZED MEDICINE
9.1 Cost Structure Analysis of Personalized Medicine
9.2 Raw Materials Cost Analysis of Personalized Medicine
9.3 Labor Cost Analysis of Personalized Medicine
9.4 Manufacturing Expenses Analysis of Personalized Medicine
CHAPTER 10 MARKETING STATUS ANALYSIS OF PERSONALIZED MEDICINE
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List
CHAPTER 11 REPORT CONCLUSION
CHAPTER 12 RESEARCH METHODOLOGY AND REFERENCE
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Reference
1.1 Definition of Personalized Medicine in This Report
1.2 Commercial Types of Personalized Medicine
1.2.1 Diagnostic
1.2.2 Therapeutics
1.2.3 Medical Care
1.2.4 Nutrition
1.2.5 Wellness
1.3 Downstream Application of Personalized Medicine
1.3.1 Hospitals
1.3.2 Molecular Diagnostic Laboratories and Testing Centers
1.3.3 Academic Institutes
1.3.4 Bio and Health Informatics Companies
1.3.5 Others
1.4 Development History of Personalized Medicine
1.5 Market Status and Trend of Personalized Medicine 2013-2023
1.5.1 EMEA Personalized Medicine Market Status and Trend 2013-2023
1.5.2 Regional Personalized Medicine Market Status and Trend 2013-2023
CHAPTER 2 EMEA MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Status of Personalized Medicine in EMEA 2013-2017
2.2 Consumption Market of Personalized Medicine in EMEA by Regions
2.2.1 Consumption Volume of Personalized Medicine in EMEA by Regions
2.2.2 Revenue of Personalized Medicine in EMEA by Regions
2.3 Market Analysis of Personalized Medicine in EMEA by Regions
2.3.1 Market Analysis of Personalized Medicine in Europe 2013-2017
2.3.2 Market Analysis of Personalized Medicine in Middle East 2013-2017
2.3.3 Market Analysis of Personalized Medicine in Africa 2013-2017
2.4 Market Development Forecast of Personalized Medicine in EMEA 2018-2023
2.4.1 Market Development Forecast of Personalized Medicine in EMEA 2018-2023
2.4.2 Market Development Forecast of Personalized Medicine by Regions 2018-2023
CHAPTER 3 EMEA MARKET STATUS AND FORECAST BY TYPES
3.1 Whole EMEA Market Status by Types
3.1.1 Consumption Volume of Personalized Medicine in EMEA by Types
3.1.2 Revenue of Personalized Medicine in EMEA by Types
3.2 EMEA Market Status by Types in Major Countries
3.2.1 Market Status by Types in Europe
3.2.2 Market Status by Types in Middle East
3.2.3 Market Status by Types in Africa
3.3 Market Forecast of Personalized Medicine in EMEA by Types
CHAPTER 4 EMEA MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Demand Volume of Personalized Medicine in EMEA by Downstream Industry
4.2 Demand Volume of Personalized Medicine by Downstream Industry in Major Countries
4.2.1 Demand Volume of Personalized Medicine by Downstream Industry in Europe
4.2.2 Demand Volume of Personalized Medicine by Downstream Industry in Middle East
4.2.3 Demand Volume of Personalized Medicine by Downstream Industry in Africa
4.3 Market Forecast of Personalized Medicine in EMEA by Downstream Industry
CHAPTER 5 MARKET DRIVING FACTOR ANALYSIS OF PERSONALIZED MEDICINE
5.1 EMEA Economy Situation and Trend Overview
5.2 Personalized Medicine Downstream Industry Situation and Trend Overview
CHAPTER 6 PERSONALIZED MEDICINE MARKET COMPETITION STATUS BY MAJOR PLAYERS IN EMEA
6.1 Sales Volume of Personalized Medicine in EMEA by Major Players
6.2 Revenue of Personalized Medicine in EMEA by Major Players
6.3 Basic Information of Personalized Medicine by Major Players
6.3.1 Headquarters Location and Established Time of Personalized Medicine Major Players
6.3.2 Employees and Revenue Level of Personalized Medicine Major Players
6.4 Market Competition News and Trend
6.4.1 Merger, Consolidation or Acquisition News
6.4.2 Investment or Disinvestment News
6.4.3 New Product Development and Launch
CHAPTER 7 PERSONALIZED MEDICINE MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
7.1 Laboratory Corporation of America
7.1.1 Company profile
7.1.2 Representative Personalized Medicine Product
7.1.3 Personalized Medicine Sales, Revenue, Price and Gross Margin of Laboratory Corporation of America
7.2 Quest Diagnostics
7.2.1 Company profile
7.2.2 Representative Personalized Medicine Product
7.2.3 Personalized Medicine Sales, Revenue, Price and Gross Margin of Quest Diagnostics
7.3 Abbott, Becton Dickinson & Co
7.3.1 Company profile
7.3.2 Representative Personalized Medicine Product
7.3.3 Personalized Medicine Sales, Revenue, Price and Gross Margin of Abbott, Becton Dickinson & Co
7.4 Siemens Healthcare Diagnostics Inc
7.4.1 Company profile
7.4.2 Representative Personalized Medicine Product
7.4.3 Personalized Medicine Sales, Revenue, Price and Gross Margin of Siemens Healthcare Diagnostics Inc
7.5 GE Healthcare
7.5.1 Company profile
7.5.2 Representative Personalized Medicine Product
7.5.3 Personalized Medicine Sales, Revenue, Price and Gross Margin of GE Healthcare
7.6 Pfizer Inc
7.6.1 Company profile
7.6.2 Representative Personalized Medicine Product
7.6.3 Personalized Medicine Sales, Revenue, Price and Gross Margin of Pfizer Inc
7.7 Sanofi
7.7.1 Company profile
7.7.2 Representative Personalized Medicine Product
7.7.3 Personalized Medicine Sales, Revenue, Price and Gross Margin of Sanofi
7.8 CardioDx
7.8.1 Company profile
7.8.2 Representative Personalized Medicine Product
7.8.3 Personalized Medicine Sales, Revenue, Price and Gross Margin of CardioDx
7.9 Asuragen Inc
7.9.1 Company profile
7.9.2 Representative Personalized Medicine Product
7.9.3 Personalized Medicine Sales, Revenue, Price and Gross Margin of Asuragen Inc
7.10 Bristol-Myers Squibb
7.10.1 Company profile
7.10.2 Representative Personalized Medicine Product
7.10.3 Personalized Medicine Sales, Revenue, Price and Gross Margin of Bristol-Myers Squibb
CHAPTER 8 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF PERSONALIZED MEDICINE
8.1 Industry Chain of Personalized Medicine
8.2 Upstream Market and Representative Companies Analysis
8.3 Downstream Market and Representative Companies Analysis
CHAPTER 9 COST AND GROSS MARGIN ANALYSIS OF PERSONALIZED MEDICINE
9.1 Cost Structure Analysis of Personalized Medicine
9.2 Raw Materials Cost Analysis of Personalized Medicine
9.3 Labor Cost Analysis of Personalized Medicine
9.4 Manufacturing Expenses Analysis of Personalized Medicine
CHAPTER 10 MARKETING STATUS ANALYSIS OF PERSONALIZED MEDICINE
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List
CHAPTER 11 REPORT CONCLUSION
CHAPTER 12 RESEARCH METHODOLOGY AND REFERENCE
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Reference
